12 completed, 3 terminated, 2 unknown, 1 active not recruiting. 21 Phase 3, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 21 | Completed 12, Terminated 3, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1 |
| Phase 2 | 6 | Completed 4, Active not recruiting 1, Terminated 1 |
Follow Magnesium: new trials by email Literature Review of Magnesium trials Research Report on Magnesium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines Magnesium, Placebo - Migraine | Phase 3 | Recruiting | Wake Forest University Health Sciences | 100 | 2025-12-16 | 2026-01-22 |
| Comparative Study of Nutraceuticals vs. Conventional Prophylactic Therapy in the Management of Migraine Propranolol 80 mg, Magnesium 400Mg - Migraine, Nutraceuticals | Phase 3 | Not yet recruiting | Fayoum University | 100 | 2025-08-20 | 2025-08-29 |
| Oral Intake of Mg in Controlled Asthmatic Patients Magnesium, ICS+LABA - Bronchial Asthma | Phase 2 / Phase 3 | Active not recruiting | Zagazig University | 166 | 2024-11-02 | 2025-08-14 |
| Efficacy of Bupivacaine-magnesium Combination Versus Bupivacaine Alone in Genicular Nerve Block genicular nerve block using bupivacaine and magnesium, genicular nerve block using bupivacaine and normal saline - Post Operative Pain | Phase 3 | Completed | Cairo University | 94 | 2024-08-01 | 2025-11-17 |
| Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple Sclerosis Transcranial Magnetic Stimulation, Amantadine Hydrochloride 100 mg (milligrams) Oral Capsule - Multiple Sclerosis, Fatigue | Phase 3 | Unknown | Hospital San Carlos, Madrid | 144 | 2022-11-28 | 2023-12-11 |
| Peri-Operative Magnesium Infusion to Prevent Atrial Fibrillation Evaluated. Magnesium sulfate - Atrial Fibrillation New Onset | Phase 2 / Phase 3 | Terminated | HagaZiekenhuis | 265 | 2022-08-01 | 2024-08-28 |
| MAGnesium Adjunction in Alcohol Withdrawal Syndrome: a Multicenter Assessment (MAGMA) Magnesium, Placebo Oral Tablet - Alcohol Withdrawal Syndrome | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 105 | 2017-11-16 | 2021-12-21 |
| Effect of Magnesium Supplement in Early Pregnancy After ICSI Magnesium Oxide, Placebo Oral Tablet - ICSI | Phase 3 | Unknown | Ain Shams University | 180 | 2017-06-01 | 2018-01-12 |
| Analgesic Efficacy of Two Adjuvants During Spinal Anaesthesia. Saline Solution, Magnesium Sulfate, Midazolam 5 MG/ML Injection - Pain, Postoperative | Phase 2 / Phase 3 | Completed | Centre de Maternité de Monastir | 150 | 2017-02-01 | 2018-03-08 |
| MLD10 in the Prevention of Migraine in Adults MLD10, Placebo - Migraine | Phase 2 / Phase 3 | Completed | Pharmalyte Solutions LLC | 157 | 2015-03-01 | 2020-10-09 |
| Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer Hydralazine/Magnesium, Placebo, Carboplatin - Cervical Cancer | Phase 3 | Withdrawn | National Institute of Cancerología | 2015-01-01 | 2025-05-29 | |
| Magnesium vs Placebo for Tonsillectomy Magnesium, Normal saline - Pain | Phase 2 / Phase 3 | Completed | Ann & Robert H Lurie Children's Hospital of Chicago | 60 | 2014-10-01 | 2019-01-03 |
| The Safety and Efficacy of a Compound Natural Health Product in Children With Attention Deficit Hyperactivity Disorder (ADHD) Compound Natural Health Product, Placebo - Attention Deficit Hyperactivity Disorder | Phase 3 | Completed | The Canadian College of Naturopathic Medicine | 16 | 2013-11-01 | 2016-01-28 |
| A Trial of Magnesium Dependent Tinnitus Magnesium, Placebo - Tinnitus | Phase 3 | Completed | Mayo Clinic | 38 | 2011-07-01 | 2015-04-30 |
| Tepilta® Versus Oxetacaine, Antacids and Placebo oxetacaine, aluminium and magnesium hydroxide, oxetacaine, magnesium and aluminium hydroxide - Radiation-induced Oesophagitis | Phase 3 | Terminated | MEDA Pharma GmbH & Co. KG | 40 | 2011-04-01 | 2022-02-07 |
| Oral Glutamine in the Prevention of Oxaliplatin-induced Neurotoxicity Glutamine, Calcium and Magnesium - Colorectal Neoplasms | Phase 3 | Completed | Sanofi | 200 | 2010-02-01 | 2013-06-21 |
| Combination Natural Health Product in Children With Attention Deficit/Hyperactivity Disorder (ADHD) Zinc, Magnesium, Vitamin B6, Vitamin C (Compound Natural Health Product for ADHD) - Attention Deficit Hyperactivity Disorder | Phase 2 / Phase 3 | Completed | Kieran Cooley | 28 | 2008-09-01 | 2015-10-19 |
| Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population Magnesium, Nifedlipine - Labor, Premature | Phase 3 | Terminated | MemorialCare | 200 | 2008-03-01 | 2009-09-18 |
| EUROPAC-2 - Pain Treatment of Hereditary and Idiopathic Pancreatitis ANTOX (vers.)1.2, Magnesium, Placebo ANTOX (vers)1.2 - Pancreatitis | Phase 3 | Completed | University Medicine Greifswald | 295 | 2005-06-06 | 2020-03-27 |
| Magnesium Effects in Apheresis magnesium - Healthy | Phase 3 | Completed | National Institutes of Health Clinical Center (CC) | 52 | 2002-06-01 | 2008-03-04 |
Showing 20 of 21. Sign in to see all of them.
Migraine Disorders (3) · Attention Deficit Disorder with Hyperactivity (2) · Impulsive Behavior (2) · Pain (2) · Pain, Postoperative (2) · Alcoholism (1) · Asthma (1) · Cardiovascular Diseases (1) · Colorectal Neoplasms (1) · Coronary Disease (1) · Delirium (1) · Fatigue (1) · Heart Diseases (1) · Hereditary pancreatitis (1) · Hypocalcemia (1)
Ain Shams University (1) · Ann & Robert H Lurie Children's Hospital of Chicago (1) · Assistance Publique - Hôpitaux de Paris (1) · Cairo University (1) · Centre de Maternité de Monastir (1) · Fayoum University (1) · HagaZiekenhuis (1) · Hospital San Carlos, Madrid (1) · Kieran Cooley (1) · MEDA Pharma GmbH & Co. KG (1) · Mayo Clinic (1) · MemorialCare (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · National Institute of Cancerología (1) · National Institutes of Health Clinical Center (CC) (1)
United States (6) · Canada (3) · Egypt (3) · Austria (1) · France (1) · Germany (1) · Mexico (1) · Netherlands (1) · Spain (1) · Tunisia (1)
Umesh Jain, MD (2) · Cetina Lucely, MSc (1) · Christopher Halloran, Professor,MD,FRCS (1) · Frank Bruns, Dr. med. (1) · Heather Boon, PhD (1) · Hubert A Benzon, MD, MPH (1) · Jeroen Ludikhuize, MD, PhD (1) · Jorge Matias-Guiu Guia, MD PhD (1) · Julia V Mayerle, Professor,MD (1) · Kenneth Chan, MD (1) · Markus M Lerch, Professor,MD (1) · Michael Cevette, PhD (1) · Rim Cherif, Dr. (1)
PMID 35947046, PMID 38176857, PMID 39148128, PMID 42206948
2009 (1), 2016 (1)